Friday, May 12, 2023 12:30 PM – 2:30 PM ET Room 206
Block Symposium
Emerging Approaches in Oncology and Autoimmunity
Chairs
- Daniela Cipolletta, Seismic Therapeut.
- Jane Grogan, Graphite Bio
Speakers
- Stephanie J. Grebinoski, Seismic Therapeut., IMPACTing autoimmunity through dual targeting of antigen presenting cells and T cells via inhibitory receptor agonism
- Hsi-Ju Wei, AbbVie, Targeting dendritic cell inhibitory receptors to down regulate immune response in inflammatory disease
- Linya Wang, Twist Biosci., Functional DKK1 antibodies demonstrate antagonistic and tumor suppression activities
- Katherine Christine Upchurch-Ange, Boehringer Ingelheim Phamaceut., Characterization of a novel therapeutic antibody targeting peptide/HLA-E
- Andrew W. Woodham, Emulate, Chimeric antigen receptor-T cell efficacy can be evaluated on an Organ-Chip model system
- Efthymia Papalexi, Parse Biosci., Using split-pool combinatorial barcoding to simultaneously characterize the transcriptome and TCR diversity of 1 million T cells
- Anushka Dikshit, Advanced Cell Diagnostics, Multiplexed RNA-protein co-detection to explore tumor-immune landscape using a novel automated RNAscope™ assay
- Daniel L. Adams, CreatvBIO, PD-L1 expression on circulating antigen presenting macrophages in blood predicts PFS & OS in an array of metastatic cancer types treated with PD-L1/PD-1 immunotherapies
